Release Summary

Millendo announces appointment of Mary Lynne Hedley, Ph.D., President of TESARO, Inc., and Carole Nuechterlein, J.D., Head of Roche Venture Fund, to its Board of Directors.

Millendo Therapeutics, Inc.